|Articles|January 15, 2002
CDC focuses on medical response to bioterrorism threat
Baltimore-The Centers for Disease Control and Prevention (CDC) has been at the forefront of the medical response to the bioterrorism threat in recent months since the first case of inhalation anthrax was identified.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
What ‘I’m Fine’ Really Means: An Open Letter from a Thyroid Eye Disease (TED) Patient
2
Opus Genetics has Type B RMAT meeting with FDA for its gene therapy candidate, OPGx-LCA5
3
PolyActiva and RareSight partner to develop treatments for rare pediatric retinal diseases
4
AAO 2025: A study of retinal vasculitis events with intravitreal agents
5














































.png)


